Varices & Liver Disease

Cirrhosis stiffens and distorts liver architecture, creating resistance to blood trying to pass through the liver. At the same time, blood flow from the intestines into the portal system can increase due to vasodilation in the splanchnic circulation. The combination raises portal pressure and drives collateral formation (varices) [2].

Portal pressure can be quantified by the hepatic venous pressure gradient (HVPG). Consensus guidance discusses key thresholds used clinically (including the concept of “clinically significant portal hypertension” and bleeding-risk thresholds) [4]. Not every patient needs HVPG testing, but understanding the concept helps explain why treatment targets are often framed around “lowering portal pressure,” not just treating a single vein.

Esophageal varices are most common. They are graded by size and risk features (such as “red wale” markings), which correlate with bleeding risk [5].

Gastric varices occur in the stomach and are classified by location and relationship to esophageal varices. Their behavior and treatment can differ from esophageal varices [6].

Ectopic varices (for example in the duodenum, colon, rectum, stomas, or abdominal wall) are less common but important, particularly when bleeding occurs from an unusual site [7].

Bleeding risk is not “all or nothing.” It is influenced by:

• Varix size (larger generally means higher risk) [5]
• Endoscopic red signs (including red wale markings), which are incorporated into validated risk indices [5]
• Severity of liver dysfunction (worse synthetic function generally increases bleeding risk) [1]
• Active triggers that destabilize cirrhosis (infection, ongoing alcohol use, kidney injury, severe vomiting/retching, and other stressors) discussed in major portal-hypertension guidance [1]

Your team uses these factors to decide whether you need medications, banding, both, or a different strategy. “High-risk varices” often means varices that warrant primary prophylaxis (treatment to prevent a first bleed) [3].

Most varices are silent until bleeding occurs. Treat these as medical emergencies:

• Vomiting blood or “coffee-ground” material
• Black, tarry stools (melena) or maroon stools
• Fainting, severe dizziness, racing heartbeat, or shock symptoms
• Sudden confusion or extreme sleepiness (bleeding can worsen encephalopathy)

Emergency evaluation and stabilization are core components of variceal-bleeding management pathways [1] [8]. If you suspect bleeding, do not drive yourself—call emergency services.

Upper endoscopy (EGD) is the standard test to diagnose and risk-stratify esophageal and many gastric varices, and it can identify high-risk stigmata that influence prevention strategies [1] [8].

Modern consensus emphasizes non-invasive risk tools (such as liver stiffness and platelet thresholds) to identify patients at very low risk of varices that need treatment—so some patients can safely defer endoscopy [2]. Your follow-up interval depends on whether varices are present, their size, and whether liver disease is stable or progressing.

Screening is not “one-and-done.” If cirrhosis worsens (new ascites, infection, rising bilirubin, falling platelets), screening and prevention plans are typically re-evaluated [3].

If you have varices that warrant prevention, two cornerstone approaches are used: non-selective beta-blockers (NSBBs) and endoscopic variceal ligation (EVL / banding) [1] [3].

NSBBs (for example propranolol, nadolol, and in many settings carvedilol) reduce portal inflow and can lower portal pressure. Choice and dosing depend on blood pressure, heart rate, kidney function, dizziness/falls risk, asthma/COPD, and other patient-specific factors [2].

EVL uses elastic bands to obliterate varices endoscopically. It is commonly used when NSBBs are not tolerated, when varices are large/high-risk, or when the clinical context favors a procedural approach. EVL typically requires several sessions spaced weeks apart until eradication, followed by surveillance [1] [8].

Prevention is not only “a varices plan.” Stabilizing cirrhosis lowers overall risk: alcohol abstinence when relevant, infection prevention and early treatment, nutrition optimization, careful diuretic management for ascites, and medication adherence all matter [3].

Varices do not automatically mean “transplant now,” but they often indicate that cirrhosis has progressed to a portal-hypertension stage associated with higher rates of decompensation events. That clinical context can influence when a transplant evaluation is initiated, how closely you are monitored, and how aggressively complications are prevented [2].

Practical transplant-related points:

• If you are being evaluated or listed, keep your transplant team informed about any endoscopies, EVL sessions, or bleeding events. Variceal bleeding is a major clinical event and can change urgency and planning [1].
• If you are on NSBBs, your team may adjust doses around procedures, infections, kidney injury, or low blood pressure episodes— do not change these medications on your own [3].
• If bleeding occurs or prevention fails, advanced therapies (including TIPS in appropriate situations) are addressed in major guidance and on your companion page [1].

Day-to-day success is mostly about follow-through: taking NSBBs exactly as prescribed (if used), showing up for EVL sessions and surveillance endoscopies (if planned), and calling early for infection symptoms, increasing abdominal distension, dizziness/falls, black stools, vomiting, or worsening confusion [3].

Many patients benefit from an “emergency sheet” (printed and on your phone) listing diagnoses (cirrhosis/portal hypertension/varices), medications, allergies, and your transplant/hepatology contact numbers. If bleeding occurs, rapid communication and accurate medication history matter [8].

• Do I have esophageal varices, gastric varices, or both—and are there high-risk features (size, red signs)? [5] [6]
• Based on my labs and non-invasive assessments, how often should I have endoscopy (or can I safely defer it right now)? [2]
• For me, is an NSBB, EVL, or a combined strategy best—and what side effects should trigger a call? [1] [3]
• What are my personal “go to the ER now” symptoms—and which hospital should I go to if bleeding is suspected? [8]
• How do varices and portal hypertension affect my transplant timing and listing strategy? [2]